Day One Biopharmaceuticals (DAWN)
(Delayed Data from NSDQ)
$13.06 USD
+0.29 (2.27%)
Updated Jun 5, 2024 04:00 PM ET
After-Market: $12.91 -0.15 (-1.15%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth A Momentum D VGM
Brokerage Reports
Day One Biopharmaceuticals, Inc. [DAWN]
Reports for Purchase
Showing records 61 - 70 ( 70 total )
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
4Q Financials; FIREFLY-1 Hits Target Enrollment; Initial Data Ahead
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q3 Financials; Data Readouts for DAY101 in 1H2022
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Q2 Financials; First Patients Dosed in FIREFLY-1
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Company: Day One Biopharmaceuticals, Inc.
Industry: Medical - Biomedical and Genetics
Initiating at OUTPERFORM and $30; Good Morning Targeted Oncology
Provider: WEDBUSH SECURITIES INC.
Analyst: DRISCOLL R